Page 108 - Read Online
P. 108

Schofield et al. J Cancer Metastasis Treat 2020;6:10  I  http://dx.doi.org/10.20517/2394-4722.2019.43                       Page 3 of 12






































               Figure 1. The glycolysis pathway. Enolases catalyse the dehydration of 2-phospho-D-glycerate (2-P-glycerate) to phosphoenolpyruvate
               (P-enolpyruvate) in the glycolysis pathway

               shuttle between compartments, performing different functions when in different subcellular locations,
               such as surface membrane plasminogen binding, controlling the overall metabolic state of the cell, stress-
               related or acting as a heat-shock protein, RNA transport, mitochondrial membrane stability, and cell cycle
               control [50-55] .


               INCREASED ALPHA-ENOLASE EXPRESSION ENHANCES CELL PROLIFERATION IN A
               VARIETY OF CANCERS
               In most solid tumours, the Warburg effect causes an increase in total glycolysis under both hypoxic and
               normoxic conditions [Figure 2]. Enhanced cell proliferation leads to increased anabolic needs, and cancer
               cells remodel metabolic processes by diverting nutrients to anabolic pathways to satisfy increased cellular
                              [56]
               energy demands . Therefore, the Warburg effect may provide cancer cells with an advantage when
               competing with non-cancerous tissues for nutrients. This suggests that increased a-enolase expression will
               contribute to enhanced proliferation commonly observed in cancer cells.


               Indeed, upregulated a-enolase expression has been shown to regulate cell proliferation in various solid
               tumours in vitro [11,13,57-61] , and to increase tumour growth in a HCT116 colorectal cancer xenograft
                           [11]
               model in vivo  [Table 2]. Conversely, silencing of a-enolase in glioma, pancreatic, lung, endometrial,
               colorectal and breast cancer cells was found to induce cell cycle arrest and senescence, and also to reduce
               tumour volume in CFPAC-1 pancreatic, MDA-MB-231 breast and U-87MG glioma xenograft models
               in vivo [6,11,12,62,63] . Furthermore, a-enolase is also implicated in the control of apoptosis and sensitivity to
               chemotherapeutic agents, as silencing of ENO1 in cancer cells induced apoptosis and increased sensitivity
               to cisplatin and 5-fluorouracil in vitro [13,62,64] . Unexpectedly, cells respond to a-enolase silencing by inducing
               catabolic adaptations that lead to restoration of pyruvate, acetyl-CoA bulk and oxidative phosphorylation,
   103   104   105   106   107   108   109   110   111   112   113